Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials
This survey study is intended to estimate the prevalence of use of CAM in patients who are
currently being treated in the Phase I Clinical Trials Program at UT MD Anderson Cancer
Center. The survey includes questions about socioeconomic characteristics (age, gender,
race, income, and education level), patients' diagnosis and patients' perceptions about
their prognosis, physicians' information and permission for patients' use of CAM, patients'
use of CAM (yes or no), decision-making (purpose of CAM use), resources and types of CAM.
Patients will be asked to drop the questionnaire into a box in a specified location after
completion of the questionnaire. Accrual is expected to be 50-100 patients per month. This
survey is expected to finish in 6 months.
Observational Model: Cohort, Time Perspective: Prospective
Prevalence of CAM use among patients enrolled in Phase I clinical trials (Questionnaire Response Rate)
Aung Naing, MD
UT MD Anderson Cancer Center
United States: Institutional Review Board
|UT MD Anderson Cancer Center||Houston, Texas 77030|